Exploration of the Impact of Ovarian Sex Cord-Stromal Tumor (SCST) Classification on Diagnostic Coding
Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v6i2.4074
Abstract
Ovarian sex cord-stromal tumors (SCSTs) are relatively rare with numerous subtypes, making preoperative diagnosis difficult. Treatment plans should be individualized based on pathological types. In practice, diagnostic coding errors frequently occur with ovarian SCSTs. According to pathology report results and combined with the WHO Classification of Female Genital Tumors, 5th edition, coding analysis involves disease diagnostic codes C56.x, D27.x, D39.1, and pathological diagnostic codes M8632/1, M8634/1, M8634/3. As key molecular alterations affecting tumor classification continue to be discovered, the integration of morphological and molecular classification has gradually replaced the previously pure morphological classification of female genital tumors, impacting diagnosis and treatment. Coders must master the latest WHO version of ovarian SCST morphological and histological classifications, promptly review differences between new and old editions, strengthen communication with pathologists and clinicians, and derive accurate coding through comprehensive analysis.
Keywords
sex cord-stromal tumor; morphological and histological classification; diagnostic coding
Full Text
PDF - Viewed/Downloaded: 3 TimesReferences
[1] Chinese Association of Reproductive Medicine Oncology Branch, Chinese Medical Doctor Association Minimally Invasive Medicine Committee Gynecologic Oncology Group, Chinese Hospital Association Obstetrics and Gynecology Hospital Branch Gynecologic Oncology Professional Group, Guangxi Medical Association Obstetrics and Gynecology Branch. Chinese Expert Consensus on Diagnosis and Treatment of Ovarian Sex Cord-Stromal Tumors (2022 Edition) [J]. Progress in Cancer, 2022, 20(21): 2161-2209.
[2] Lu Shanshan, Shen Danhua. Updates and Interpretation of the 5th Edition WHO Classification of Female Genital Tumors [J]. Chinese Journal of Obstetrics and Gynecology, 2021, 8: 588-592.
[3] Chen Xiaoduan. WHO Histological Classification of Ovarian Tumors (2003) and Advances in Pathological Diagnosis [C]. Proceedings of the 8th National Academic Conference on Obstetrics and Gynecology Pathology and Advanced Training for Obstetrics and Gynecology Pathologists, 2005: 22-33.
[4] Gai Xiaojing, Zhao Wencui, Yu Fengsheng, Yu Xiao, He Yixuan, Yao He, Wang Wenjie, Wang Yankui. A Case Report and Literature Review of Ovarian Steroid Cell Tumor [J]. Progress in Clinical Medicine, 2022, 12(12): 11163-11168.
[2] Lu Shanshan, Shen Danhua. Updates and Interpretation of the 5th Edition WHO Classification of Female Genital Tumors [J]. Chinese Journal of Obstetrics and Gynecology, 2021, 8: 588-592.
[3] Chen Xiaoduan. WHO Histological Classification of Ovarian Tumors (2003) and Advances in Pathological Diagnosis [C]. Proceedings of the 8th National Academic Conference on Obstetrics and Gynecology Pathology and Advanced Training for Obstetrics and Gynecology Pathologists, 2005: 22-33.
[4] Gai Xiaojing, Zhao Wencui, Yu Fengsheng, Yu Xiao, He Yixuan, Yao He, Wang Wenjie, Wang Yankui. A Case Report and Literature Review of Ovarian Steroid Cell Tumor [J]. Progress in Clinical Medicine, 2022, 12(12): 11163-11168.
Copyright © 2025 Xuying Bai, Hongxia Sun
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
